0001562180-19-003969.txt : 20190717 0001562180-19-003969.hdr.sgml : 20190717 20190717160237 ACCESSION NUMBER: 0001562180-19-003969 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190717 FILED AS OF DATE: 20190717 DATE AS OF CHANGE: 20190717 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: IGUCHI KIMI CENTRAL INDEX KEY: 0001304815 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36544 FILM NUMBER: 19959182 MAIL ADDRESS: STREET 1: 100 FOXBOROUGH BOULEVARD STREET 2: SUITE 240 CITY: FOXBOROUGH STATE: MA ZIP: 02035 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Sage Therapeutics, Inc. CENTRAL INDEX KEY: 0001597553 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 215 FIRST STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-299-8380 MAIL ADDRESS: STREET 1: 215 FIRST STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 4 1 primarydocument.xml PRIMARY DOCUMENT X0306 4 2019-07-17 false 0001597553 Sage Therapeutics, Inc. SAGE 0001304815 IGUCHI KIMI C/O SAGE THERAPEUTICS, INC. 215 FIRST STREET CAMBRIDGE MA 02142 false true false false CFO & Treasurer Common Stock 2019-07-17 4 M false 4000.00 1.36 A 10409.00 D Stock Option (Right to Buy) 1.36 2019-07-17 4 M false 4000.00 0.00 D 2024-01-24 Common Stock 4000.00 8698.00 D Reflects beneficial ownership balance which includes 273 ESPP shares purchased on June 30, 2019. The stock option award was issued pursuant to the Sage Therapeutics, Inc. 2011 Stock Option and Incentive Plan. The option vested in full on January 1, 2018. /s/ Anne Marie Cook, as Attorney-in-Fact for Kimi Iguchi 2019-07-17